This brand name is authorized in Nigeria.
The drug ORFE-C contains one active pharmaceutical ingredient (API):
1
|
UNII
PQ6CK8PD0R - ASCORBIC ACID
|
|
Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-1810 | Tablet | ORFE-C CHEWABLE TABLET TAB 100 mg X 1000s, X 100 | 6 RNW-PP-136738 ORFE-C CHEWABLE TABLET VITAMIN C VITAMIN C 100MG A4-1810 Drugs Nigerian Products 1000s,100 OTC 8/2/2022 ORFEMA PHARMACEUTICAL INDUSTRY LIMITED, 5, ATILADE ADEBOWALE STREET, OFF DADDY SAVAGE ROAD, OFF IJU ROAD 14537852 info@orfema.com ORFEMA PHARMACEUTICAL INDUSTRY LIMITED, 5, ATILADE ADEBOWALE STREET, FAGBA – IJU, LAGOS STATE. , Nigeria | 21/12/2023 |
| A4-4844 | Chewable tablet | ORFE-C WHITE TABLET TAB_CHEW 100 mg X 1000, X 100 | 7 RNW-PP-137347 ORFE-C WHITE TABLET VITAMIN C VITAMIN C 100MG A4-4844 Drugs Nigerian Products 1000,100 OTC 8/2/2022 ORFEMA PHARMACEUTICAL INDUSTRY LIMITED, 5, ATILADE ADEBOWALE STREET, OFF DADDY SAVAGE ROAD, OFF IJU ROAD 14537852 info@orfema.com ORFEMA PHARMACEUTICAL INDUSTRY LIMITED, 5, ATILADE ADEBOWALE STREET, FAGBA – IJU, LAGOS STATE. , Nigeria | 21/12/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A11GA01 | Ascorbic acid (vit C) | A Alimentary tract and metabolism → A11 Vitamins → A11G Ascorbic acid (Vitamin C), incl. combinations → A11GA Ascorbic acid (vitamin C), plain |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-1810, A4-4844 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.